Decreased opioid medication use by 21 percent compared to other minimally-invasive spine surgical techniques NEW YORK, Sept. 20, 2024 /PRNewswire/ — An emerging type of minimally-invasive spine surgery reduces the use of pain medication in […]
Tag: Medical Pharmaceuticals
AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine (ELAHERE®) for the Treatment of Certain Adult Ovarian Cancer
NORTH CHICAGO, Ill., Sept. 20, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization […]
Bioretec’s Shareholders’ Nomination Board appointed
TAMPERE, Finland, Sept. 20, 2024 /PRNewswire/ — The following persons have been appointed to Bioretec’s Shareholders’ Nomination Board: Kustaa Poutiainen, Chair and Founder of Stephen Industries Inc Oy as Chair and Karoliina Lindroos, Head of Responsible Investment of Ilmarinen […]
Bioretec’s Shareholders’ Nomination Board appointed
TAMPERE, Finland, Sept. 20, 2024 /PRNewswire/ — The following persons have been appointed to Bioretec’s Shareholders’ Nomination Board: Kustaa Poutiainen, Chair and Founder of Stephen Industries Inc Oy as Chair and Karoliina Lindroos, Head of Responsible Investment of Ilmarinen […]
RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U.S. as first and only targeted regimen to cut risk of disease progression by more than half in second-line EGFR-mutated advanced lung cancer
Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT® this year, with four indications overall RARITAN, N.J., Sept. 17, 2024 /PRNewswire/ — Johnson & […]